AJG vs ALL Stock Comparison

Scores Breakdown

Metric	AJG	ALL
📈 Growth	14/30	22/30
💰 Profitability	14/20	14/20
🏦 Financial Health	16/20	18/20
💵 Valuation	8/20	10/20
⚠️ Risk (lower is better)	5/10	6/10
Overall Score	57/100	68/100

Side-by-Side Summaries

AJG Analysis	ALL Analysis
📈 Growth & Financial Trajectory From 2024 Q2 to 2026 Q1 AJG exhibits a roller-coaster 8-quarter path. Revenue rose to a peak of $4.758B in 2026 Q1 but ended the window at $2.8068B in 2024 Q2, a decline of about 41% over the span. Net income followed a similar volatile pattern, moving from $823M in 2026 Q1 to $285.4M in 2024 Q2, with a notable trough in 2025 Q4 ($210.5M). The sequence includes a mid-window high around 2025 Q1 ($704.4M) before subsiding. Overall, the backdrop shows upside momentum into early 2026 after mid-2024 troughs, but the end-state remains materially below the peak start level. These dynamics imply improving but uneven near-term growth and earnings power. 💰 Margins & Cash Flow Profitability relief is uneven. Gross-margin proxy (revenues minus costs) fluctuates, with an early-2026 reading around 21.9% (4,758 vs 3,715) but a dip in 2025 Q4 near 5%, reflecting mix/cost pressure. A rising trend into 2025–2026 suggests improving operating leverage, albeit from a weak mid-2024 base. Operating cash flow remained positive in most quarters, notably $957M in 2026 Q1 and $753M in 2025 Q1, while total cash flow was pressured by investing/financing outflows in quarters like 2025 Q2. Cash flow patterns indicate solid core cash generation, offset by episodic outlays. 🛡️ Balance Sheet & Liquidity AJG carries a sizeable asset base with total assets around $78B (2026 Q1), current assets about $42B and current liabilities near $39.5B, yielding a modest current ratio (~1.06). Long‑term debt sits around $12–13B across recent quarters, with equity around $23–24B. The balance sheet shows solid liquidity and reasonable leverage (debt to equity well below 1), supporting resilience through cyclicality. ⚠️ Key Drivers & Risks Drivers: stable insurance brokerage demand and diversified risk-management services; potential uplift from data-driven analytics. Risks: revenue/earnings cyclicality, sensitivity to pricing and tax mix, and episodic volatility from large capital/dividend outlays could pressure near-term earnings and multiple.	📈 Growth & Financial Trajectory Across 8 quarters, Allstate’s revenue rose from about $15.714B (2024-Q2) to about $16.941B (2026-Q1), up roughly 7.8%. Net income climbed from about $0.347B to $2.458B, a multi‑fold increase, with a notable surge in late‑2025 before a softer start in 2026. The trend is positive overall but shows quarterly volatility (e.g., 2025‑Q1 dip followed by stronger 2025‑Q3/Q4). End‑period profitability remains sensitive to cost structure and mix, yet margins improved from multi‑quarter lows to mid‑teens late in 2025 and into 2026. 💰 Margins & Cash Flow Operating margin ranged from about 2.7% (2024‑Q2) to about 28.4% (2025‑Q4), with several quarters in the mid‑teens, indicating substantial margin volatility but a capability to leverage scale when costs align with revenues. Net cash flow from operating activities remained positive in all quarters, averaging around $3.0B per quarter; notably, 2026‑Q1 shows operating cash flow near $3.56B. Investing cash flow was often negative, reflecting capital allocation and reserve considerations, while financing activity flow fluctuated, contributing to variances in overall cash balance. 🛡️ Balance Sheet & Liquidity Current assets consistently exceed current liabilities, yielding a healthy current ratio around 1.3x (roughly 1.29–1.34 over periods). Long‑term debt sits near $8.08B with total liabilities largely dominated by insurance reserves and operating liabilities, while equity (≈$21–31B across periods) provides a meaningful buffer; periods show equity around $24–31B and liabilities near $92–93B. ⚠️ Key Drivers & Risks Drivers: prudent pricing and reserving practices within P&C insurance; managing catastrophe exposure and capital allocation. Risks: quarterly earnings are sensitive to claim volatility and reserve adequacy; macro factors and regulatory changes can impact pricing and claims experience, affecting valuation sensitivity and downside scenarios.

AJG Analysis

ALL Analysis

📈 Growth & Financial Trajectory

From 2024 Q2 to 2026 Q1 AJG exhibits a roller-coaster 8-quarter path. Revenue rose to a peak of $4.758B in 2026 Q1 but ended the window at $2.8068B in 2024 Q2, a decline of about 41% over the span. Net income followed a similar volatile pattern, moving from $823M in 2026 Q1 to $285.4M in 2024 Q2, with a notable trough in 2025 Q4 ($210.5M). The sequence includes a mid-window high around 2025 Q1 ($704.4M) before subsiding. Overall, the backdrop shows upside momentum into early 2026 after mid-2024 troughs, but the end-state remains materially below the peak start level. These dynamics imply improving but uneven near-term growth and earnings power.

💰 Margins & Cash Flow

Profitability relief is uneven. Gross-margin proxy (revenues minus costs) fluctuates, with an early-2026 reading around 21.9% (4,758 vs 3,715) but a dip in 2025 Q4 near 5%, reflecting mix/cost pressure. A rising trend into 2025–2026 suggests improving operating leverage, albeit from a weak mid-2024 base. Operating cash flow remained positive in most quarters, notably $957M in 2026 Q1 and $753M in 2025 Q1, while total cash flow was pressured by investing/financing outflows in quarters like 2025 Q2. Cash flow patterns indicate solid core cash generation, offset by episodic outlays.

🛡️ Balance Sheet & Liquidity

AJG carries a sizeable asset base with total assets around $78B (2026 Q1), current assets about $42B and current liabilities near $39.5B, yielding a modest current ratio (~1.06). Long‑term debt sits around $12–13B across recent quarters, with equity around $23–24B. The balance sheet shows solid liquidity and reasonable leverage (debt to equity well below 1), supporting resilience through cyclicality.

⚠️ Key Drivers & Risks

Drivers: stable insurance brokerage demand and diversified risk-management services; potential uplift from data-driven analytics.
Risks: revenue/earnings cyclicality, sensitivity to pricing and tax mix, and episodic volatility from large capital/dividend outlays could pressure near-term earnings and multiple.

📈 Growth & Financial Trajectory

Across 8 quarters, Allstate’s revenue rose from about $15.714B (2024-Q2) to about $16.941B (2026-Q1), up roughly 7.8%. Net income climbed from about $0.347B to $2.458B, a multi‑fold increase, with a notable surge in late‑2025 before a softer start in 2026.

The trend is positive overall but shows quarterly volatility (e.g., 2025‑Q1 dip followed by stronger 2025‑Q3/Q4). End‑period profitability remains sensitive to cost structure and mix, yet margins improved from multi‑quarter lows to mid‑teens late in 2025 and into 2026.

💰 Margins & Cash Flow

Operating margin ranged from about 2.7% (2024‑Q2) to about 28.4% (2025‑Q4), with several quarters in the mid‑teens, indicating substantial margin volatility but a capability to leverage scale when costs align with revenues.
Net cash flow from operating activities remained positive in all quarters, averaging around $3.0B per quarter; notably, 2026‑Q1 shows operating cash flow near $3.56B.
Investing cash flow was often negative, reflecting capital allocation and reserve considerations, while financing activity flow fluctuated, contributing to variances in overall cash balance.

🛡️ Balance Sheet & Liquidity

Current assets consistently exceed current liabilities, yielding a healthy current ratio around 1.3x (roughly 1.29–1.34 over periods).
Long‑term debt sits near $8.08B with total liabilities largely dominated by insurance reserves and operating liabilities, while equity (≈$21–31B across periods) provides a meaningful buffer; periods show equity around $24–31B and liabilities near $92–93B.

⚠️ Key Drivers & Risks

Drivers: prudent pricing and reserving practices within P&C insurance; managing catastrophe exposure and capital allocation.
Risks: quarterly earnings are sensitive to claim volatility and reserve adequacy; macro factors and regulatory changes can impact pricing and claims experience, affecting valuation sensitivity and downside scenarios.

Similar Companies

AON Score: 81

Top Rated Companies

View Top 20 →

MU "MICRON TECHNOLOGY INC"

AVGO "Broadcom Inc."

KMI "KINDER MORGAN, INC."

MNST "Monster Beverage Corp"

NEM "NEWMONT Corp /DE/"